Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#102 / 199 Total
ZVSA - ZyVersa Therapeutics Inc - Stock Price Chart
TickerZVSA [NASD]
CompanyZyVersa Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap3.72MEPS (ttm)-75.45
P/E-EPS this Y98.62%
Forward P/E-EPS next Y-206.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.33EPS Q/Q-1067.67%
Dividend-Sales Q/Q-
Insider Own0.12%Inst Own11.47%
Insider Trans0.00%Inst Trans-
Short Float1.88%EarningsMay 15/b
Analyst Recom1.00Target Price70.00
Avg Volume413.54K52W Range4.44 - 180.25
May-15-24 11:53PM ZVSA Stock Earnings: ZyVersa Therapeutics Misses EPS for Q1 2024 (InvestorPlace) -6.62%
08:35AM ZyVersa Therapeutics Reports First Quarter, 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Convention (GlobeNewswire)
Apr-29-24 07:57AM ZyVersa Therapeutics Announces Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities in Patients with Alzheimer's Disease (GlobeNewswire) +15.63%
Apr-04-24 07:57AM ZyVersa Therapeutics Highlights Published Data Demonstrating NLRP3 Inflammasome Inhibition Has Potential to Decrease Atherosclerotic Lesions in Patients with Diabetes (GlobeNewswire)
Mar-25-24 08:17AM ZyVersa Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-18-24 07:57AM ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator VAR 200 in Patients with Diabetic Kidney Disease (GlobeNewswire) +8.79%
Mar-14-24 07:57AM ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled Inflammation Illuminated, at Benzinga's Virtual Healthcare Summit 2024 on March 20, 2024 (GlobeNewswire)
Feb-29-24 07:57AM ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity (GlobeNewswire) +10.00%
Feb-28-24 07:57AM ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100's Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications (GlobeNewswire) -8.26%
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.
SWVL - Swvl Holdings Corp - Stock Price Chart
TickerSWVL [NASD]
CompanySwvl Holdings Corp
CountryUnited Arab Emirates
IndustrySoftware - Application
Market Cap57.38MEPS (ttm)0.46
P/E18.35EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.51EPS next 5Y-
P/B6.41EPS Q/Q-90760.29%
Dividend-Sales Q/Q-
Insider Own46.03%Inst Own1.37%
Insider Trans0.00%Inst Trans-
Short Float2.36%EarningsDec 27/b
Analyst Recom3.00Target Price37.50
Avg Volume113.07K52W Range0.62 - 21.94
Swvl Holdings Corp. engages in the provision of mass transit and shared mobility solutions. It provides transportation services through contracting with other service providers or transportation operators. The company was founded on February 8, 2017 and is headquartered in Dubai, United Arab Emirates.
SRTS - Sensus Healthcare Inc - Stock Price Chart
TickerSRTS [NASD]
CompanySensus Healthcare Inc
CountryUSA
IndustryMedical Devices
Market Cap97.19MEPS (ttm)0.29
P/E20.77EPS this Y544.44%
Forward P/E16.03EPS next Y91.38%
PEG-EPS past 5Y-
P/S3.07EPS next 5Y-
P/B1.90EPS Q/Q219.55%
Dividend-Sales Q/Q212.33%
Insider Own21.31%Inst Own15.05%
Insider Trans0.00%Inst Trans19.65%
Short Float0.24%EarningsMay 09/a
Analyst Recom1.00Target Price8.67
Avg Volume517.66K52W Range1.79 - 6.45
Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sardano Joseph CCHIEF EXECUTIVE OFFICERSep 14 '23Buy2.8810,00028,7731,175,293Sep 18 11:04 AM
Sardano MichaelPRESIDENT AND GENERAL COUNSELAug 28 '23Buy2.991,0002,99058,774Aug 28 02:27 PM
Sardano Joseph CCHIEF EXECUTIVE OFFICERAug 08 '23Buy3.8610,00038,5741,165,293Aug 08 02:43 PM
Sardano MichaelPRESIDENT AND GENERAL COUNSELAug 08 '23Buy3.781,0003,77857,774Aug 08 02:44 PM
IFBD - Infobird Co Ltd - Stock Price Chart
TickerIFBD [NASD]
CompanyInfobird Co Ltd
CountryChina
IndustrySoftware - Application
Market Cap4.90MEPS (ttm)-6.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.67EPS next 5Y-
P/B2.69EPS Q/Q97.28%
Dividend-Sales Q/Q-100.00%
Insider Own0.14%Inst Own0.13%
Insider Trans0.00%Inst Trans-
Short Float9.65%Earnings-
Analyst Recom1.00Target Price9976.00
Avg Volume903.12K52W Range3.44 - 395.20
Infobird Co. Ltd. engages in the provision of standard and customized customer relationship management cloud-based services. It offers software-as-a-service (SaaS) and business process outsourcing (BPO) services to clients, through its variable interest entity. The company was founded in 2001 and is headquartered in Beijing, China.
HITI - High Tide Inc. - Stock Price Chart
TickerHITI [NASD]
CompanyHigh Tide Inc.
CountryCanada
IndustryPharmaceutical Retailers
Market Cap166.41MEPS (ttm)-0.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-7.01%
P/S0.45EPS next 5Y-
P/B1.69EPS Q/Q92.08%
Dividend-Sales Q/Q8.16%
Insider Own9.66%Inst Own7.83%
Insider Trans0.00%Inst Trans-
Short Float6.47%EarningsMar 15/a
Analyst Recom-Target Price-
Avg Volume714.85K52W Range1.14 - 2.85
High Tide, Inc. is a retail-focused cannabis company, which engages in the manufacture and distribution of consumption accessories. It operates through the following segments: Retail, Wholesale, and Corporate. Its brands are Canna Cabana, Fastendr, Grasscity, Smoke Cartel, Daily High Club, DankStop, NuLeaf Naturals, FAB CBD, Blessed CBD, Valiant Distribution, and Famous Brandz. The company was founded by Harkirat Grover in 2009 and is headquartered in Calgary, Canada.
SDIG - Stronghold Digital Mining Inc - Stock Price Chart
TickerSDIG [NASD]
CompanyStronghold Digital Mining Inc
CountryUSA
IndustryCapital Markets
Market Cap35.15MEPS (ttm)-3.00
P/E-EPS this Y88.87%
Forward P/E-EPS next Y6.02%
PEG-EPS past 5Y-68.53%
P/S0.41EPS next 5Y-
P/B0.56EPS Q/Q105.40%
Dividend-Sales Q/Q59.40%
Insider Own16.04%Inst Own16.80%
Insider Trans-15.28%Inst Trans2.73%
Short Float4.56%EarningsMay 02/b
Analyst Recom1.67Target Price7.17
Avg Volume508.30K52W Range1.65 - 11.56
Stronghold Digital Mining, Inc. is a vertically integrated crypto asset mining company, which engages in mining Bitcoin. It operates the Energy Operations and Cryptocurrency Operations segments. The company was founded by Gregory Allan Beard and William B. Spence on March 19, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Matthew J.Chief Financial OfficerMay 03 '24Sale3.29132434174,207May 07 06:01 PM
Shaffer Richard J.Senior Vice PresidentMay 01 '24Sale3.124313427,125May 02 05:41 PM
Smith Matthew J.Chief Financial OfficerApr 23 '24Sale3.65107391174,339Apr 24 07:15 PM
Beard Gregory AChief Executive OfficerApr 15 '24Sale2.3813,81132,818374,003Apr 17 07:33 PM
Smith Matthew J.Chief Financial OfficerMar 20 '24Sale4.04166670174,446Mar 22 06:32 PM
ADAP - Adaptimmune Therapeutics Plc ADR - Stock Price Chart
TickerADAP [NASD]
CompanyAdaptimmune Therapeutics Plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap283.61MEPS (ttm)-0.73
P/E-EPS this Y-682.22%
Forward P/E-EPS next Y1.63%
PEG-EPS past 5Y10.30%
P/S15.47EPS next 5Y1.00%
P/B11.64EPS Q/Q-3280.95%
Dividend-Sales Q/Q-88.19%
Insider Own4.81%Inst Own52.01%
Insider Trans-1.33%Inst Trans-0.50%
Short Float1.45%EarningsMay 15/b
Analyst Recom2.00Target Price2.86
Avg Volume1.48M52W Range0.42 - 2.05
Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rawcliffe AdrianChief Executive OfficerJan 17 '24Sale0.6730,08020,24444,848Jan 17 05:31 PM
Bertrand William C JRChief Operating OfficerJan 17 '24Sale0.6718,90812,7257,785Jan 17 05:30 PM
Norry ElliotChief Medical OfficerJan 17 '24Sale0.6718,27612,3007,785Jan 17 05:31 PM
Lunger JohnChief Patient Supply OfficerJan 17 '24Sale0.6718,11412,1917,785Jan 17 05:30 PM
Rawcliffe AdrianChief Executive OfficerJan 16 '24Sale0.799,3047,35014,104Jan 17 05:31 PM
CYRX - CryoPort Inc - Stock Price Chart
TickerCYRX [NASD, RUT]
CompanyCryoPort Inc
CountryUSA
IndustryIntegrated Freight & Logistics
Market Cap623.14MEPS (ttm)-2.47
P/E-EPS this Y36.26%
Forward P/E-EPS next Y21.31%
PEG-EPS past 5Y-45.48%
P/S2.77EPS next 5Y-
P/B1.40EPS Q/Q-172.16%
Dividend-Sales Q/Q-13.09%
Insider Own2.31%Inst Own105.08%
Insider Trans-7.12%Inst Trans-0.40%
Short Float8.68%EarningsMay 07/a
Analyst Recom2.20Target Price17.89
Avg Volume486.94K52W Range9.00 - 23.50
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERMAN RICHARD JDirectorMay 15 '24Sale13.418,105108,693100,000May 16 05:30 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerMay 14 '24Sale13.373,44346,04260,051May 15 07:28 PM
SHELTON JERRELLChief Executive OfficerMar 25 '24Sale17.542,63146,154692,182Mar 26 08:09 PM
Sawicki Mark WChief Scientific OfficerMar 25 '24Sale17.541,36723,98077,444Mar 26 08:08 PM
STEFANOVICH ROBERTChief Financial OfficerMar 25 '24Sale17.541,07918,928128,333Mar 26 08:12 PM
INTZ - Intrusion Inc - Stock Price Chart
TickerINTZ [NASD]
CompanyIntrusion Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap5.36MEPS (ttm)-8.44
P/E-EPS this Y80.04%
Forward P/E-EPS next Y49.67%
PEG-EPS past 5Y-
P/S0.99EPS next 5Y-
P/B-EPS Q/Q79.53%
Dividend-Sales Q/Q-13.60%
Insider Own59.49%Inst Own1.23%
Insider Trans44.08%Inst Trans12.78%
Short Float9.36%EarningsMay 14/a
Analyst Recom2.00Target Price11.25
Avg Volume226.60K52W Range1.50 - 34.40
Intrusion, Inc. is a cybersecurity company, which offers customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company was founded by T. Joe Head and G. Ward Paxton in September 1983 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott AnthonyChief Executive OfficerApr 22 '24Buy1.70585,748995,772638,281Apr 25 08:11 AM
PINSON KIMBERLYChief Financial OfficerApr 22 '24Buy1.7010,00017,00015,076Apr 25 08:10 AM
LEVECCHIO ANTHONY JDirectorApr 04 '24Option Exercise2.918,33424,25220,611Apr 04 06:46 PM
Scott AnthonyChief Executive OfficerApr 02 '24Option Exercise2.9133,33497,00252,533Apr 04 06:54 PM
PINSON KIMBERLYChief Financial OfficerApr 02 '24Option Exercise2.913,3349,7025,076Apr 04 06:51 PM
NIVF - NewGenIvf Group Ltd - Stock Price Chart
TickerNIVF [NASD]
CompanyNewGenIvf Group Ltd
CountryTaiwan
IndustryHealth Information Services
Market Cap4.21MEPS (ttm)-0.21
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.27EPS Q/Q-569.60%
Dividend-Sales Q/Q-
Insider Own-Inst Own35.21%
Insider Trans-Inst Trans2.24%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume6.04M52W Range0.63 - 17.24
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
167891011121314151620